Oxidative Stress in Schizophrenia
Author Information
Author(s): Bošković Marija, Vovk Tomaž, Kores Plesničar Blanka, Grabnar Iztok
Primary Institution: Faculty of Pharmacy, University of Ljubljana
Hypothesis
The study reviews the role of oxidative stress in schizophrenia and explores potential biomarkers and therapeutic strategies.
Conclusion
Oxidative stress is involved in the pathology of schizophrenia, and there is a need for better biomarkers and therapeutic strategies.
Supporting Evidence
- Oxidative damage is common in schizophrenia and may contribute to poor outcomes.
- Antioxidant enzymes and lipid peroxidation markers are commonly used to assess oxidative stress.
- Vitamin E may improve tardive dyskinesia, but evidence for polyunsaturated fatty acids is unclear.
- Peripheral biomarkers may not accurately reflect oxidative status in the central nervous system.
Takeaway
This study looks at how oxidative stress affects people with schizophrenia and suggests ways to help them feel better.
Methodology
The study reviewed existing literature and data from various databases to analyze oxidative stress in schizophrenia.
Limitations
The study highlights the need for well-designed, placebo-controlled trials to confirm findings.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website